Average Co-Inventor Count = 9.17
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (40 from 3,223 patents)
2. Xenon Pharmaceuticals Inc. (15 from 109 patents)
3. Array Biopharma Inc. (11 from 329 patents)
4. F. Hoffmann-La Roche Ag (3 from 168 patents)
5. Medimmune Limited (2 from 541 patents)
6. Bolt Biotherapeutics, Inc. (1 from 7 patents)
7. Covenentech, Inc. (1 from 1 patent)
8. Genertech, Inc. (1 from 1 patent)
9. Hoffman-Laroche, Inc. (US Only) (1 from 1 patent)
10. F. Hoffman-Laroche, Ag (Ex-US) (1 from 1 patent)
11. Leland Stanford Junior University (5,312 patents)
46 patents:
1. 12139496 - Therapeutic compounds and methods of use thereof
2. 11692043 - Peptidomimetic compounds and antibody-drug conjugates thereof
3. 11654199 - Thienoazepine immunoconjugates, and uses thereof
4. 11149002 - Therapeutic compounds and methods of use thereof
5. 11130726 - Therapeutic compounds and methods of use thereof
6. 10947251 - Therapeutic compounds and methods of use thereof
7. 10899732 - Substituted benzamides useful as sodium channel blockers
8. 10787446 - Therapeutic compounds and methods of use thereof
9. 10711004 - Oxadiazole transient receptor potential channel inhibitors
10. 10632210 - Peptidomimetic compounds and antibody-drug conjugates thereof
11. 10544215 - 1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
12. 10533058 - Peptidomimetic compounds and antibody-drug conjugates thereof
13. 10526285 - Therapeutic compounds and methods of use thereof
14. 10442836 - 1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
15. 10179767 - Substituted benzamides and methods of use thereof